Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S ADR
(NY:
NVO
)
137.57
+0.51 (+0.37%)
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novo Nordisk A/S ADR
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
57
58
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 04, 2024
Pre-market stock movers are a hot topic this morning as we cover all of the biggest market news traders need to know about on Thursday!
Via
InvestorPlace
Missed Out on Eli Lilly? My Best Pharmaceutical Stock to Buy And Hold
January 03, 2024
The past three years were bliss for Eli Lilly shareholders, but those not already on board should look at its rival instead.
Via
The Motley Fool
1 Stock-Split Stock to Buy Hand Over Fist in 2024 and 1 to Avoid
January 03, 2024
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a historically cheap outperformer that's ripe for the picking, as well as an...
Via
The Motley Fool
3 Biotech Stocks at the Forefront of the Quest for Eternal Youth
January 02, 2024
Biotech stocks targeting longevity could uncover the fountain of youth in coming years, offering a prime investment opportunity today.
Via
InvestorPlace
While growth is established for NYSE:NVO, the stock's valuation remains reasonable.
January 02, 2024
NYSE:NVO is showing decent growth, but is still valued reasonably.
Via
Chartmill
Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity
December 27, 2023
Via
Benzinga
(NVO) - Analyzing Novo Nordisk's Short Interest
December 25, 2023
Via
Benzinga
New Year Resolution Stocks: Can Getting Fitter Be A Winner On The Stock Market?
January 02, 2024
Novo Nordisk's shares gained 50.7% in 2023 thanks largely to sales of its weight loss drugs, while Eli Lilly's shares have jumped 60.7%.
Via
Benzinga
Weight Watchers gains from Oprah’s GLP-1 weight-loss
January 02, 2024
Oprah Winfrey revealed she has lost over 60 pounds and is on the path to reaching her weight goal of 167 lbs. She credits this to taking GLP-1 medication
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
2024’s Power Players: 7 Stocks Racing to a Trillion Valuation
January 01, 2024
Whether in 2024, or in the years ahead, each of these seven stocks could become the next trillion dollar companies.
Via
InvestorPlace
Prediction: These 3 Stocks Will Soar in 2024
January 01, 2024
Investors could enjoy an especially happy new year with these great stocks.
Via
The Motley Fool
Here's How Much $1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth Today
December 21, 2023
Via
Benzinga
3 Ken Griffin Stocks to Invest Like Citadel
December 30, 2023
Invest like Citadel founder and billionaire Ken Griffin with these stocks that have strong potential heading into 2024.
Via
InvestorPlace
These 3 Companies Can Be the Next Stock-Split Stocks in 2024
December 29, 2023
Since mid-2021, Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk have conducted stock splits. Three well-known companies look set to follow in...
Via
The Motley Fool
Meet the Stock-Split Stock Warren Buffett Is Likeliest to Buy in 2024
December 27, 2023
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a stock-split stock that checks all the right boxes for the Oracle of Omaha.
Via
The Motley Fool
3 Stock-Split Stocks Billionaires Are Piling Into Ahead of 2024
December 25, 2023
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three industry leaders Wall Street's brightest money managers want to own for...
Via
The Motley Fool
Novo Nordisk, Maker Of 'Miracle' Weight Loss Drug Ozempic, Announces Mega Factory In Dublin
December 24, 2023
Via
Benzinga
Will Novo Nordisk Be Worth More Than Meta Platforms by 2030?
December 23, 2023
The gap in market cap between these two companies is big today, but it could shrink in the future.
Via
The Motley Fool
Fake Ozempic - FDA and Novo Nordisk Warn Against Counterfeit Ozempic Penetrating US Market Amid High Demand
December 22, 2023
The FDA on Thursday said it continues to investigate counterfeit Novo Nordisk A/S's&n
Via
Benzinga
Exposures
Product Safety
7 Low-Volatility Stocks for Stable Growth in 2024
December 21, 2023
Wager on these stocks to buy for stable growth, handpicked for their low volatility and potential to weather economic headwinds.
Via
InvestorPlace
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
December 21, 2023
Which weight-loss stocks are good buys today?
Via
The Motley Fool
Looking to Invest in the Next Big Craze Like Ozempic? This 1 Emerging Field Could Be It.
December 21, 2023
Diabetes and weight-loss drugs won't be the hottest category of medicines forever.
Via
The Motley Fool
Why Novo Nordisk Stock Was Up on a Down Day for the Market
December 20, 2023
As if the company's top two products weren't popular enough, a new media report made them even more appealing.
Via
The Motley Fool
Weight Loss Drugs By Novo Nordisk, Eli Lilly Don't Deter Nestle's Coffee Demand - CEO Explains Why
December 20, 2023
Nestle S.A. (OTC: NSRGY) CEO Mark Schneider stated that despite the rising use of weight loss medications like Eli Lilly And Company's (NYSE: LLY) Zepbound and Novo Nordisk's
Via
Benzinga
These 2 Unstoppable Stocks Could Make You Richer in 2024 and Beyond
December 20, 2023
Eli Lilly and Novo Nordisk are disrupting the weight-loss market with treatments like Mounjaro and Ozempic.
Via
The Motley Fool
Novo Nordisk Collaborates With India's Online Marketplace To Remove Unauthorized Wegovy Listings
December 19, 2023
IndiaMART, an online marketplace in India, has reportedly taken action to remove unauthorized listings of Novo Nordisk A/S's (NYSE: NVO) highly sought-after weight-loss drug Wegovy after engaging in...
Via
Benzinga
LifeMD expands telehealth GLP-1weight-loss service with Medifast
December 19, 2023
LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing
Via
MarketBeat
3 Stocks With the Potential to Be 2024’s Company of the Year
December 18, 2023
Finding the top stocks for 2024 is like looking for a needle in a haystack. Nonetheless, some of these names could be company of the year.
Via
InvestorPlace
Obesity/Diabetes Drug Class GLP-1s' Cost-Saving Potential: Decoding Impact on Healthcare Spending
December 18, 2023
Due to the recent achievements of GLP-1s, Goldman Sachs sees significant potential for Eli Lilly And Co (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), and other companies to venture
Via
Benzinga
Wegovy's Success Spurs Novo Nordisk Foundation's Philanthropic Initiative To Enhance Respiratory Disease Vaccines
December 18, 2023
The Novo Nordisk Foundation pledged 1.8 billion Danish crowns ($265 million) toward an initiative to enhance vaccines for respiratory illnesses.
Via
Benzinga
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
57
58
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.